Our news

Leaders in CAR-T cell treatment, HCL treats its 500th adult patient with this revolutionary therapy

Pierre Stephan, Roberta Di Blasi, Louise Roulin, Jean Galtier, Julien Calvani, Veronique Meignin, Marie Donzel, Alexandra Traverse-Glehen, Elsa Poullot, Marie-Cécile Parrens, Vivien Dupont, Alexandra Marquet, Steven Le Gouill , Roch Houot, Francois-Xavier Gros, François Lemonnier, Emmanuel Bachy, Catherine Thieblemont, Pierre Sesques

Nicolas Gazeau, David Beauvais, Rémi Tilmont, Micha Srour, Emmanuelle Ferrant, Violaine Safar, Ludovic Fouillet, Pascale Flandrin-Gresta, Nicolas Gower, Paul Chauvet, Nicolas Duployez, Benjamin Podvin, Julie Demaret, Sarah Huet, Pierre Sujobert, Hervé Ghesquières, Gandhi Damaj, Emmanuel Bachy, Franck Morschhauser, Ibrahim Yakoub-Agha, Maël Heiblig, Pierre Sesques

Guillaume Cartron, Roch Houot, Yassine Al Tabaa, Fabien Le Bras, Loïc Ysebaert, Sylvain Choquet, Fabrice Jardin, Jacques-Olivier Bay, François-Xavier Gros, Franck Morschhauser, Olivier Casasnovas, Thomas Gastinne, Catherine Thieblemont, Magalie Joris, Laure Ricard, Caroline Regny, Laurianne Drieu La Rochelle, Pierre Feugier, Ambroise Marcais, Samuel Griolet, Karin Tarte, Camille Laurent, Pierre Sesques

We would like to inform you that the 2025 Haematology Days will be held on 13 March, 17 April and 15 May for the staff of the hematology department of the Lyon Sud Hospital. This unique event will gather experts, health professionals and researchers to discuss this year the theme of clinical research .

The Inserm LIB research team led by Prof. Emmanuel Bachy is the winner of this European call for proposals for the development of new treatments of peripheral T-cell lymphomas. With a total funding of nearly €2 million for the European consortium, including €300,000 directly allocated to the Lyon research team, the objective is to discover new therapeutic targets based on a detailed analysis of the tumor microenvironment in this type of lymphoma, whose prognosis remains particularly poor.

We are pleased to inform you of the organization of the Regional Post ASH Day, which will be held on March 21, 2025 at the Lyon Sud University Hospital. This event is a unique opportunity to share scientific information and news on the latest advances in the field of hematology (allografts, AML and ALL, myelodysplastic syndromes, lymphomas, benign haematology, PNH, aplasia and myeloproliferative syndromes, multiple myeloma and CLL). We hope to see many of you for this event that brings together the hematological community of the region.

Bartlett NL, Hahn U, Kim WS, Fleury I, Laribi K, Bergua JM, Bouabdallah K, Forward N, Bijou F, MacDonald D, Portell CA, Ghesquieres H, Nowakowski G, Yasenchak CA, Patterson M, Ho L, Rustia E, Fanale M, Jie F, Kim JA